Sentynl
1 known investors
A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
Founders & leadership
MH
Matt HeckinFounder & CEO
Investors · 1
Frequently asked questions
- What does Sentynl do?
- A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
- Who founded Sentynl?
- Sentynl was founded by Matt Heck.
- Who are Sentynl's investors?
- Sentynl's investors include Avego BioScience Capital.